Thermo Fisher Scientific has announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California.
The 6,000-square-foot facility will offer clinical and commercial process development support to help cell therapy developers transition from research-scale to CGMP manufacturing. The ATxCC will offer customers access to innovative technologies such as laboratory equipment and analytical solutions; protocol and process optimization support; and dedicated regulatory and quality support as therapeutic programs evolve.
In 2023, Thermo established a similar collaboration center in Singapore, which serves as the Asia Pacific hub for CGT development and commercialization. The company also has a facility in Korea.
With all eyes on domestic manufacturing, Thermo Fisher says it also plans to expand its footprint in Philadelphia later this year.
Subscribe to our e-Newsletters
Stay up to date with news, articles and insights relevant to cell and gene therapy development and manufacturing. Plus, get special offers from Cell & Gene Therapy Review delivered right to your inbox!
Sign up now!